To use optical coherence tomography angiography (OCTA) to evaluate foveal microvascular changes in diabetes by comparing the area of foveal avascular zone (FAZ) in healthy controls and patients with diabetes with no diabetic retinopathy (NDR) as well as different stages of diabetic retinopathy (DR). A systematic literature search was performed based on the population, intervention, comparison and outcome (PICO) strategy by two independent reviewers. The search was performed in PubMed, Embase and Cochrane Library, including keywords 'diabetes mellitus', 'DR' and 'OCTA'. Of 358 studies initially identified, 215 studies were screened after duplicate removal. Of these, we included 12 (nine crosssectional and three retrospective) studies in this review. With the data at hand, it was not possible to perform a meta-analysis. The selected studies included patients with NDR (n = 8), non-proliferative diabetic retinopathy (NPDR, n = 8) and proliferative diabetic retinopathy (PDR, n = 6). Several of the studies provided information for more than one diabetic group. In general, there was a trend towards a larger area of FAZ in patients with diabetes. As compared to healthy controls, this was reported in patients with NDR (five of eight studies), NPDR (seven of eight studies) and PDR (six of six studies). Optical coherence tomography angiography (OCTA) is non-invasively able to identify foveal capillary non-perfusion as an early event in DR. In some studies, this has even been identified in patients without clinically identifiable microvascular lesions. Longitudinal studies would be needed to examine if OCTA-findings are able to predict long-term structural and functional outcome.
Introduction
Diabetes mellitus (DM) is a chronic disease on the rise worldwide (International Diabetes Federation 2017) . The disease is estimated to affect 693 million people by the year 2045 (International Diabetes Federation 2017) . Patients with DM are at risk of developing diabetic retinopathy (DR) which is the leading cause of blindness in the working age of developed countries (Klein 1987) .
Diabetic retinopathy (DR) is a neurovascular degenerative disease caused by multifactorial and complex mechanisms (Zeng & Chen 2014; Pusparajah et al. 2016) . These mechanisms involve several pathways leading to oxidative stress, increased pro-inflammatory mediators and increased vascular endothelial growth factor secretion (Pusparajah et al. 2016 ). This induces changes in the retinal microvasculature and involves development of microaneurysms, capillary non-perfusion, vascular leakage and neovascularization (Rema & Pradeepa 2007) . As classified by the Early Treatment DR Study (ETDRS), DR can be divided into mild, moderate, severe non-proliferative DR (NPDR), and proliferative DR (PDR) (Early Treatment Diabetic Retinopathy Study Research Group 1991) . The examination of DR is today performed by fundus photography (Andersen et al. 2016; Al-Sheikh et al. 2016) , and timely detection and intervention is crucial to prevent vision loss.
The foveal avascular zone (FAZ) is a capillary-free region forming a ring at the foveal margin (Provis et al. 2000; Zheng et al. 2010 ). This region is nourished by diffusion from the underlying choroidal circulation (Delaey & Van De Voorde 2000) . Diabetic changes in the retinal microvasculature may lead to changes in FAZ, which again may cause visual impairment (Balaratnasingam et al. 2016) . Foveal avascular zone (FAZ) has traditionally been examined invasively by fundus fluorescein angiography (FFA) (Freiberg et al. 2016 ). This method requires intravenous injection of fluorescein dye making it time-consuming and unpleasant to patients (Zheng et al. 2010; Samara et al. 2017 ). Due to its invasive character, it is usually not performed in early stages of DR, and it has, therefore, not been used as a screening tool (Wiley & Ferris 2013) .
Optical coherence tomography angiography (OCTA) is a rapid and noninvasive examination of the retinal blood flow (de Carlo et al. 2015a,b; Spaide et al. 2015) . This method uses motion of erythrocytes to detect the flow in the retinal capillaries (Takase et al. 2015; Bhanushali et al. 2016; Simonett et al. 2017) . It also has the ability to separate the superficial retinal layer (SRL) and deep retinal layer (DRL), as well as detecting microvascular details and capillary changes (Ishibazawa et al. 2015; Matsunaga et al. 2015; Bhanushali et al. 2016) . To reduce picture artefacts and extracting angiographic data, including area of FAZ, several algorithms have been developed over the last few years Shahlaee et al. 2016) .
The aim of this systematic review was to evaluate foveal microvascular changes with OCTA by comparing the area of FAZ between healthy controls and patients with diabetes and different levels of DR.
Materials and Methods

Literature search
A systematic search based on population, intervention, comparison and outcome strategy (PICO) was performed. The study population consisted of diabetic patients with no DR (NDR), NPDR and PDR. We used OCTA as intervention and further compared the three groups to healthy controls to investigate differences in the area of FAZ using OCTA.
Searches were done in Pubmed, Embase and the Cochrane Library on September 10, 2017. All searches were performed with a wide focus to prevent any missed articles. No filters were used. The search and screening of the articles were performed by two independent reviewers. When a disagreement occurred, the relevant article was discussed between the reviewers until consensus was reached.
In Pubmed we used all available fields, including MeSH-terms. The search string used was: (OCTA OR 'optical coherence tomography angiography' OR 'OCT angiography' OR 'optical coherence tomographic angiography') AND (diabetes OR diabetes mellitus OR diabetic OR diabetic retinopathy OR diabetes retinopathy). In Embase, we performed a search using emtree with the explode function. The search yielded 132 results in PubMed, 224 in Embase and two in Cochrane, which in total gave 358 studies. After removal of duplicates, this resulted in 215 studies.
Literature selection
The titles and abstracts were screened and selected based on the inclusion and exclusion criteria. The inclusion criteria were: (i) English used as language, (ii) humans subjects, (iii) patients with DM as the investigated group, (iv) patients without DM and with healthy eyes as the control group, (v) specified stage of DR, (vi) OCTA as method for investigation, (vii) full-article online, and (viii) measurements of area of FAZ in each study group. Exclusion criteria were: (i) animal studies, (ii) case reports, (iii) systematic reviews and (iv) conference abstracts.
After the initial screening, 32 articles remained, all of which were read in full-text format by both reviewers. The full-text screening resulted in 12 articles, eight which included NDR, eight including NPDR and six including PDR (Fig. 1) . The articles removed from the study involved conference abstracts, not specified level of DR, missing values for FAZ, letter to editor, missing data for control group or provided only diameter of FAZ.
Results
This review identified 12 articles investigating the area of FAZ in diabetic patients ( Table 1) . Eight of the articles studied NDR patients (de Carlo et al. 2015a,b; Takase et al. 2015; Di et al. 2016; Salz et al. 2016; Carnevali et al. 2017; Dimitrova et al. 2017; Goudot et al. 2017; Lee et al. 2017 ), eight articles studied NPDR patients (Takase et al. 2015; Al-Sheikh et al. 2016; Bhanushali et al. 2016; Di et al. 2016; Salz et al. 2016; Lee et al. 2017; Lupidi et al. 2017; Samara et al. 2017 ) and six of the articles studied PDR patients (Al-Sheikh et al. 2016; Bhanushali et al. 2016; Di et al. 2016; Salz et al. 2016; Lee et al. 2017; Samara et al. 2017) . Several of the articles provided information for more than one diabetic group. All measurements of the area of FAZ, if not specified, are given with standard deviation (SD). Carnevali et al. (2017) analysed retinal vascular plexuses and choriocapillaries in patients with type 1 DM. Both the NDR group and the control group consisted of 25 eyes (25 patients) each. Mean duration of DM was 11 AE 4 years, and there was no difference in the mean age (22 AE 2 years in the NDR group and 23 AE 2 years in the control group, p = 0.12). In SRL, the mean area of FAZ was 0.22 AE 0.10 mm 2 in the diabetic group, and 0.25 AE 0.10 mm 2 in the control group (p = 0.34). In DRL, the mean area of FAZ was 0.75 AE 0.20 mm 2 in the diabetic group and 0.76 AE 0.23 mm 2 in the control group (p = 0.81).
de Carlo et al. (2015a,b) studied early microvascular changes in NDR patients. The study included 61 diabetic eyes (39 patients) and 28 healthy eyes (22 patients). Duration of DM was not specified. No difference in the mean age was found (60 AE 21 years in the diabetic group and 54 AE 12 years in the control group, p = 0.12). The mean area of FAZ was larger in the diabetic group, 0.35 AE 0.10 mm 2 , compared to the control group, 0.29 AE 0.14 mm 2 (p = 0.04). Dimitrova et al. (2017) compared retinal and choriocapillary vascular flow parameters in NDR patients and healthy individuals. The NDR group consisted of 29 eyes (29 patients) and the control group 33 healthy eyes (33 patients). Mean duration of DM was 7 AE 6 years. No difference in the mean age was found (69 AE 9 years in the NDR group and 65 AE 11 years in the control group, p = 0.13). The mean area of FAZ, only measured in SRL, was larger in the NDR group, 0.37 AE 0.11 mm 2 , compared to the control group, 0.31 AE 0.10 mm 2 (p = 0.02). The control group included 85 healthy eyes (62 patients). Mean duration of DM was 10 AE 6 years. The mean age was 57 AE 11 years in the DR group and 54 AE 13 years in the control group (no calculation for difference presented). The mean area of FAZ was larger when comparing the NDR group, 0.40 AE 0.16 mm 2 (p = 0.04), NPDR group 0.40 AE 0.11 mm 2 (p = 0.02) and PDR groups, 0.47 AE 0.18 mm 2 (p < 0.01), to the control group, 0.36 AE 0.11 mm 2 . Lee et al. (2017) studied vessel tortuosity in DR patients. They included 121 eyes from diabetic patients (81 patients); 31 eyes with NDR, 26 eyes with mild NPDR, 31 eyes with moderate to severe NPDR and 33 eyes with PDR. The control group consisted of 30 healthy eyes (23 patients). Mean DM duration was 10 AE 5 years in the NDR group, 16 AE 11 years in the mild NPDR group, 12 AE 9 years in the moderate to severe NPDR and 21 AE 15 years in the PDR group. No difference was found in the mean age (59 AE 12 years in the NDR group, 64 AE 9 years in the mild NPDR group, 62 AE 7 years in the moderate to severe NPDR groups, 60 AE 7 years in the PDR group and 57 AE 11 years in the control group, p = 0.09). A statistically significant enlargement in the mean area of FAZ was only found in DRL in the PDR group compared to the control group, (p = 0.029). (2016) quantified FAZ and the perifoveal intercapillary area in diabetic eyes. The diabetic group consisted of 29 eyes; 13 eyes with NDR, 11 eyes with NPDR and 5 eyes with PDR. The control group consisted of 11 healthy eyes. Duration of DM was not specified. No difference between the mean age was found (56 AE 10 years in the diabetic group and 55 AE 6 years in the control group, p = 0.35). The mean area of FAZ was statistically significant larger in all the diabetic groups compared to the control group (p < 0.05 for all). The mean FAZ area was 0.41 AE 0.19 mm 2 in the NDR group, 0.49 AE 0.19 mm 2 in the NPDR group, 0.76 AE 0.16 mm 2 in the PDR group and 0.30 AE 0.11 mm 2 in the control group. Takase et al. (2015) studied the area of FAZ in diabetic and healthy eyes. They included 44 diabetic patients; 24 eyes with NDR (24 patients) and 20 eyes with NPDR (20 patients). The control group consisted of 19 healthy eyes (19 patients). Mean duration of DM was 6 AE 4 years in the NDR group and 18 AE 9 years in the NPDR group. No difference was seen in mean age (63 AE 10 years in the NDR group, 66 AE 9 years in the NPDR group and 63 AE 11 years in the control group, p = 0.56). The mean area of FAZ was measured in SRL and DRL. It presented a statistically significant Lupidi et al. (2017) investigated the foveal microvasculature in NPDR. The NPDR group consisted of 48 eyes (48 patients) and the control group consisted of 47 eyes (47 patients). Duration of DM was not specified. The mean age was 58 years (range: 20-78) in the diabetic group and 40 years (range: 19-66) in the control group (with not test for differences presented). The mean area of FAZ was statistically significant enlarged in both SRL and DRL, when comparing the diabetic group to the control group (p < 0.05). In SRL, the mean area of FAZ was 0.42 AE 0.15 mm 2 in the NPDR group and 0.28 AE 0.11 mm 2 in the control group. The mean area of FAZ was in DRL 0.45 AE 0.15 mm 2 in the diabetic group, and 0.30 AE 0.10 mm 2 in the control group. Samara et al. (2017) quantified the area of FAZ in patients with DR. They included 84 eyes (55 patients) with DR; 32 eyes with mild NPDR, 31 eyes with moderate to severe NPDR and 21 eyes with PDR. Thirty four healthy control eyes (27 patients) were used. Duration of DM was not specified. No difference was found in the mean age (61 AE 14 years in the mild NPDR group, 66 AE 11 years in the moderate to severe NPDR group, 59 AE 9 years in the PDR group and 62 AE 11 years in the control group, p = 0.17). The mean area of FAZ was enlarged in both SRL and DRL, when comparing the diabetic group to the control group. In SRL the mean area of FAZ was 0.37 AE 0.13 mm 2 in mild NPDR (p = 0.013), 0.44 AE 0.20 mm 2 in moderate-to-severe NPDR (p < 0.001), 0.51 AE 0.31 mm 2 in the PDR group (p < 0.001) and 0.28 AE 0.11 mm 2 in the control group. In DRL the mean area of FAZ was 0.51 AE 0.19 mm 2 in the mild NPDR (p = 0.002) group, 0.63 AE 0.25 mm 2 in the moderate-tosevere NPDR group (p < 0.001), 0.77 AE 0.34 mm 2 in the PDR group (p < 0.001) and 0.37 AE 0.11 mm 2 in the control group.
Discussion
Changes in the area of FAZ and other parameters of the retinal vasculature
We found eight studies investigating the area of FAZ in NDR patients. Five of these found a statistically significantly larger area of FAZ when comparing NDR patients to healthy controls. Although Goudot et al. (2017) and Lee et al. (2017) did not confirm this, they still found larger absolute values of the mean area of FAZ in the NDR group. Eight articles investigated the area of FAZ in NPDR patients. Seven of these articles found a larger area as compared to the healthy control group. This includes Al-Sheikh et al. (2016) that found a larger result in all subgroups in DRL and in the severe NPDR group in SRL but on the other hand no differences in patients with mild and moderate NPDR in the SRL. Lee et al. (2017) was the only study that did not report enlargement in the area of FAZ. Six studies investigated patients with PDR. All of these found a larger area in the PDR group as compared to the control group, except for Lee et al. (2017) in the SRL. In summary, most articles found increased foveal capillary non-perfusion in patients with diabetes as compared to healthy controls with a tendency towards a stronger correlation in patients with advanced levels of DR.
In DR, enlargement of FAZ happens due to the loss of capillaries in the adjacent vessels (Bresnick et al. 1984) . The microvascular changes and macular ischemia are more pronounced in the later stages of DR (Wu et al. 2013 ). However, in the studies investigated there were no differences in the area of FAZ between the NDR and NPDR groups. Salz et al. (2016) and Samara et al. (2017) were the only studies of those investigating PDR, which described FAZ-enlargement in the PDR group as compared to the other diabetic subgroups. Lee et al. (2017) described the area of FAZ to increase as DR progresses. In summary, the studies we investigated found increasing values in the area of FAZ along with increasing severity of DR, but this was only statistically significant in a few studies.
The use of OCTA allows the retinal layers to be visualized separately (Bhanushali et al. 2016) . Some of the studies investigated SRL and DRL independently and several of them found FAZ to be enlarged in both layers when comparing the diabetic patients to the healthy controls. Just two studies investigated if there was a difference between SRL and DRL, and only Lupidi et al. (2017) described a statistically significant difference. The observation that DRL might be more affected by capillary drop-out than SRL may be due to the different blood supply of the layers. The deep capillaries around FAZ have terminal architecture, while the superficial capillaries have a continuous ring around the perifoveal vascular arcade (Lupidi et al. 2017) . Al-Sheikh et al. (2016) found general enlargement of both layers (except for SRL in mild and moderate NPDR). Another explanation for diverging results between the two layers may be due to problems with segmentation, causing the layers to be visualized together and implementing inaccurate results (Lupidi et al. 2016) .
Several factors might influence the area of FAZ. Among these, age has been proposed, but Bhanushali et al. (2016) and Durbin et al. (2017) were not able to demonstrate a correlation between age and FAZ. A substantial interpersonal variability in the area of FAZ has been reported between agematched groups in both healthy and diabetic patients (Conrath et al. 2005; Tam et al. 2011) . This could represent a limitation for using the area of FAZ at a population-based level as a possible diagnostic tool. The duration of DM was investigated in several of the studies. None of these studies found the FAZ size to be correlated with the duration of DM, with exception of Lee et al. (2017) and Bhanushali et al. (2016) which did not specify their findings. In a comparison between studies reporting an elevated area of FAZ in diabetes and those that did not, we could not find any confounding explanations regarding potential differences in age, duration of diabetes or number of patients.
Some of the articles studied for this review investigated several parameters when examining DR patients. Amongst these were vessel density, spacing between vessel and perfusion density. According to the study of Bhanushali et al. (2016) and Durbin et al. (2017) area of FAZ had the lowest sensitivity and specificity when compared to the other parameters investigated. This finding may be due to the high interindividual variability in the area of FAZ (Conrath et al. 2005; Tam et al. 2011) . Therefore, area of FAZ may be used as a part of the diagnostic procedure for DR in the future, but may be unsuitable as a parameter used alone.
For the studies included in the present review, FAZ was examined in several ways including measurements of perimeter (Lee et al. 2017; Lupidi et al. 2017) , radius (Di et al. 2016 ) and irregularity (de Carlo et al. 2015a,b) . However, these methods were not compared, and so far there is no general agreement regarding which method to use of FAZ-measurement.
OCTA
Foveal avascular zone (FAZ) has been examined over the last decades using FFA (Freiberg et al. 2016 ). Due to the invasive nature of FFA, it is not used in the early stages of DR (Wiley & Ferris 2013) . The development of OCTA allows FAZ to be examined non-invasively (Spaide et al. 2015; Lupidi et al. 2017 ). In addition, OCTA also has the advantage of visualizing the different layers of FAZ separately, which is not possible with FFA (Spaide et al. 2015; Samara et al. 2017) . When considering all the advantages of the OCTA technique, we also find several limitations. Optical coherence tomography angiography (OCTA) provides only a limited field of view, typically 3 9 3 mm (de Carlo et al. 2015a,b) . Larger areas may be scanned, but at the expense of limited resolution (de Carlo et al. 2015a,b; Al-Sheikh et al. 2016) . Optical coherence tomography angiography (OCTA) requires several seconds of fixation, which may be problematic for some patients (Di et al. 2016; Freiberg et al. 2016 ). This could result in faulty or unsatisfactory images (de Carlo et al. 2015a,b) . Due to this fact, several studies did not include patients with large impairments of vision, with the risk for selection bias and misleading results. Despite these limitations, OCTA has several advantages and may have a role in future diagnosing and monitoring of DR.
Limitations to the included studies
There are some limitations in the included studies. First, most of the included studies were small; only four (Bhanushali et al. 2016; Di et al. 2016; Lee et al. 2017; Samara et al. 2017 ) had a total of more than 100 eyes. Second, none of the studies described how their patients were included. Hence, we cannot rule of selection bias given that some patients may have been recruited at specialized centres that predominantly treat patients with advanced disease. Third, measurements of FAZ were not performed blinded in all studies. Carnevali et al. (2017) did not describe who manually outlined the area of FAZ or if the reader was blinded. Bhanushali et al. (2016) , Lee et al. (2017) and Samara et al. (2017) used an automatic algorithm without the need of manual interpretation. We cannot rule out that different methods of measurements may cause bias. Fourth, generalization may be impaired given that some of the studies excluded a large number of patients due to motion artefacts and poor image quality. For example, Samara et al. (2017) excluded 22% of the diabetic eyes and de Carlo et al. (2015a,b) excluded 24%. Fifth, some of the included studies extracted data from both eyes of the same patients. This may represent a limitation given the high correlation between eyes from the same patient. Hence, it is often considered to be standard of care only to include one eye from each patient.
Limitations to our systematic review
Our systematic review has limitations too. First, we found only eight studies investigating NDR, eight studies investigating NPDR and six studies investigating PDR. This means it involves limited data available for a general conclusion. Second, the studies involved used several different types of OCTAmachines and algorithms, which may represent diverging results. Third, three of the studies included patients with diabetic macular oedema (DMO). Di et al. (2016) found a statistically significant (p = 0.017) larger area in patients with DMO as compared to those without. Al-Sheikh et al. (2016) and Salz et al. (2016) did not provide the measured values for these groups, making it difficult for us to exclude the possibility of potential bias. Fourth, most studies did not specify which type of diabetes they included in their study groups. In this review, we included patients with both type 1 and type 2 DM, since we were unable to differentiate the data. In addition to this, the duration of DM may also have influenced the changes seen in the area of FAZ. Fifth, the included studies were cross-sectional studies, which are not able to separate cause from effect.
Conclusion
Based on this systematic review we found a trend of increased foveal capillary drop-out in patients with diabetes as compared to healthy controls. In particular, this was evident for patients with advanced levels of DR. Larger prospective studies are needed to evaluate if macular OCTAmeasurements can be used as an early non-invasive marker of DR onset or progression.
